With a Covid-19 vaccine patent waiver likely, time to rethink global intellectual property rules

Updated 7:36 AM ET, Fri May 7, 2021

Ruth L. Okediji is the Jeremiah Smith Jr. Professor of Law at Harvard Law School. The views expressed in this commentary belong solely to the author. Read more from As Equals. For information about how the series is funded and more